Large-scale investigation of leishmania interaction networks with host extracellular matrix by surface plasmon resonance imaging

Infection and Immunity

Volumn 82, Issue 2, 2014, Pages 594-606

  Fatoux Ardore, Marie ^a   Peysselon, Franck ^a   Weiss, Anthony ^b   Bastien, Patrick ^c   Pratlong, Francine ^c   Ricard Blum, Sylvie ^a  

^a INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 6; ENDOSTATIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; PROTOZOAL PROTEIN; SCLEROPROTEIN; TROPOELASTIN; VASCULOTROPIN;

ARTICLE; CARBOHYDRATE ANALYSIS; EXTRACELLULAR MATRIX; HOST PATHOGEN INTERACTION; LEISHMANIA; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

ANIMALS; CELL ADHESION; EXTRACELLULAR MATRIX PROTEINS; GLYCOSAMINOGLYCANS; HOST-PATHOGEN INTERACTIONS; HUMANS; LEISHMANIA; PROTEIN BINDING; SURFACE PLASMON RESONANCE;

EID: 84892978777     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01146-13     Document Type: Article

References (53)

1. World Health Organization. 2010. Control of the leishmaniases. WHO Technical Report Series 949.World Health Organization, Geneva, Switzerland.
2. Milon G. 2009. Perpetuation of Leishmania: some novel insight into elegant developmental programs. Vet. Res. 40:38. http://dx.doi.org/10.1051 /vetres/2009021.
3. Moreno I, Domínguez M, Cabañes D, Aizpurua C, Toraño A. 2010. Kinetic analysis of ex vivo human blood infection by Leishmania. PLoS Negl. Trop. Dis. 4:e743. http://dx.doi.org/10.1371/journal.pntd.0000743.
4. Kaye P, Scott P. 2011. Leishmaniasis: complexity at the host-pathogen interface. Nat. Rev. Microbiol. 9:604-615. http://dx.doi.org/10.1038/nrmicro2608.
5. McGwire BS, Chang K-P, Engman DM. 2003. Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease gp63. Infect. Immun. 71:1008-1010. http://dx .doi.org/10.1128/IAI.71.2.1008-1010.2003.
6. Lira R, Rosales-Encina JL, Argüello C. 1997. Leishmania mexicana: binding of promastigotes to type I collagen. Exp. Parasitol. 85:149-157. http://dx.doi.org/10.1006/expr.1996.4127.
7. Kulkarni MM, Jones EA, McMaster WR, McGwire BS. 2008. Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation. Infect. Immun. 76:1738-1747. http://dx.doi.org/10 .1128/IAI.01274-07.
8. Ghosh A, Kole L, Bandyopadhyay K, Sarkar K, Das PK. 1996. Evidence of a laminin binding protein on the surface of Leishmania donovani. Biochem. Biophys. Res. Commun. 226:101-106. http://dx.doi.org/10 .1006/bbrc.1996.1317.
9. Mukhopadhyay NK, Shome K, Saha AK, Hassell JR, Glew RH. 1989. Heparin binds to Leishmania donovani promastigotes and inhibits protein phosphorylation. Biochem. J. 264:517-525.
10. Butcher BA, Sklar LA, Seamer LC, Glew RH. 1992. Heparin enhances the interaction of infective Leishmania donovani promastigotes with mouse peritoneal macrophages. A fluorescence flow cytometric analysis. J. Immunol. 148:2879-2886.
11. Love DC, Esko JD, Mosser DM. 1993. A heparin-binding activity on Leishmania amastigotes which mediates adhesion to cellular proteoglycans. J. Cell Biol. 123:759-766. http://dx.doi.org/10.1083/jcb.123.3.759.
12. Faye C, Chautard E, Olsen BR, Ricard-Blum S. 2009. The first draft of the endostatin interaction network. J. Biol. Chem. 284:22041-22047. http: //dx.doi.org/10.1074/jbc.M109.002964.
13. Faye C, Inforzato A, Bignon M, Hartmann DJ, Muller L, Ballut L, Olsen BR, Day AJ, Ricard-Blum S. 2010. Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells. Biochem. J. 427: 467-475. http://dx.doi.org/10.1042/BJ20091594.
14. Symoens S, Renard M, Bonod-Bidaud C, Syx D, Vaganay E, Malfait F, Ricard-Blum S, Kessler E, Van Laer L, Coucke P, Ruggiero F, De Paepe A. 2011. Identification of binding partners interacting with the α1-Npropeptide of type V collagen. Biochem. J. 433:371-381. http://dx.doi.org /10.1042/BJ20101061.
15. Wyler DJ, Sypek JP, McDonald JA. 1985. In vitro parasite-monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite attachment. Infect. Immun. 49:305-311.
16. Bandyopadhyay K, Karmakar S, Ghosh A, Das PK. 2002. High affinity binding between laminin and laminin binding protein of Leishmania is stimulated by zinc and may involve laminin zinc-finger like sequences.Eur. J. Biochem. 269:1622-1629. http://dx.doi.org/10.1046/j.1432-1327 .2002.02793.x.
17. de Castro Côrtes LM, de Souza Pereira MC, de Oliveira FO, Jr, Corte-Real S, da Silva FS, Pereira BAS, de Fátima Madeira M, de Moraes MTB, Brazil RP, Alves CR. 2012. Leishmania (Viannia) braziliensis: insights on subcellular distribution and biochemical properties of heparinbinding proteins. Parasitology 139:200-207. http://dx.doi.org/10.1017 /S0031182011001910.
18. Martin SL, Vrhovski B, Weiss AS. 1995. Total synthesis and expression in Escherichia coli of a gene encoding human tropoelastin. Gene 154:159-166. http://dx.doi.org/10.1016/0378-1119(94)00848-M.
19. Wu WJ, Vrhovski B, Weiss AS. 1999. Glycosaminoglycans mediate the coacervation of human tropoelastin through dominant charge interactions involving lysine side chains. J. Biol. Chem. 274:21719-21724. http: //dx.doi.org/10.1074/jbc.274.31.21719.
20. Ricard-Blum S, Féraud O, Lortat-Jacob H, Rencurosi A, Fukai N, Dkhissi F, Vittet D, Imberty A, Olsen BR, van der Rest M. 2004. Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations. J. Biol. Chem. 279:2927-2936. http://dx.doi.org/10.1074/jbc.M309868200.
21. Faye C, Moreau C, Chautard E, Jetne R, Fukai N, Ruggiero F, Humphries MJ, Olsen BR, Ricard-Blum S. 2009. Molecular interplay between endostatin, integrins, and heparan sulfate. J. Biol. Chem. 284: 22029-22040. http://dx.doi.org/10.1074/jbc.M109.002840.
22. Scarano S, Mascini M, Turner APF, Minunni M. 2010. Surface plasmon resonance imaging for affinity-based biosensors. Biosens. Bioelectron. 25: 957-966. http://dx.doi.org/10.1016/j.bios.2009.08.039.
23. Johnson M, Zaretskaya I, Raytselis Y, Merezhuk Y, McGinnis S, Madden TL. 2008. NCBI BLAST: a better web interface. Nucleic Acids Res. 36:W5-W9. http://dx.doi.org/10.1093/nar/gkn201.
24. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T. 2011. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27:431-432. http://dx.doi.org/10.1093/bioinformatics/btq675.
25. Chautard E, Fatoux-Ardore M, Ballut L, Thierry-Mieg N, Ricard-Blum S. 2011. MatrixDB, the extracellular matrix interaction database. Nucleic Acids Res. 39:D235-D240. http://dx.doi.org/10.1093/nar/gkq830.
26. Toida T, Yoshida H, Toyoda H, Koshiishi I, Imanari T, Hileman RE, Fromm JR, Linhardt RJ. 1997. Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem. J. 322(Part 2):499-506.
27. Avilan L, Calcagno M, Figuera M, Lemus L, Puig J, Rodriguez AM. 2000. Interaction of Leishmania mexicana promastigotes with the plasminogen-plasmin system. Mol. Biochem. Parasitol. 110:183-193. http: //dx.doi.org/10.1016/S0166-6851(00)00269-3.
28. Cryan LM, Rogers MS. 2011. Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy. Front. Biosci. 16:1574-1588. http://dx.doi.org/10.2741/3806.
29. Ricard-Blum S, Ballut L. 2011. Matricryptins derived from collagens and proteoglycans. Front. Biosci. 16:674-697. http://dx.doi.org/10.2741/3712.
30. Waterhouse A, Bax DV, Wise SG, Yin Y, Dunn LL, Yeo GC, Ng MKC, Bilek MMM,Weiss AS. 2011. Stability of a therapeutic layer of immobilized recombinant human tropoelastin on a plasma-activated coated surface. Pharm. Res. 28: 1415-1421. http://dx.doi.org/10.1007/s11095-010-0327-z.
31. Galal AM, Gul W, Slade D, Ross SA, Feng S, Hollingshead MG, Alley MC, Kaur G, ElSohly MA. 2009. Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity. Bioorg. Med. Chem. 17:741-751. http://dx.doi.org /10.1016/j.bmc.2008.11.050.
32. Zhang P, Nicholson DE, Bujnicki JM, Su X, Brendle JJ, Ferdig M, Kyle DE, Milhous WK, Chiang PK. 2002. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. J. Biomed. Sci. 9:34-40. http://dx.doi.org/10.1007/BF02256576.
33. Neskey DM, Ambesi A, Pumiglia KM, McKeown-Longo PJ. 2008. Endostatin and anastellin inhibit distinct aspects of the angiogenic process. J. Exp. Clin. Cancer Res. 27:61. http://dx.doi.org/10.1186/1756-9966-27-61.
34. de Castro Côrtes LM, de Souza Pereira MC, da Silva FS, Pereira BAS, de Oliveira FO, Jr, de Araújo Soares RO, Brazil RP, Toma L, Vicente CM, Nader HB, de Fátima Madeira M, Bello FJ, Alves CR. 2012. Participation of heparin binding proteins from the surface of Leishmania (Viannia) braziliensis promastigotes in the adhesion of parasites to Lutzomyia longipalpis cells (Lulo) in vitro. Parasit. Vectors 5:142. http://dx.doi .org/10.1186/1756-3305-5-142.
35. Louassini M, Adroher FJ, Foulquié MR, Benítez R. 1998. Investigations on the in vitro metacyclogenesis of a visceral and a cutaneous human strain of Leishmania infantum. Acta Trop. 70:355-368. http://dx.doi.org/10 .1016/S0001-706X(98)00041-2.
36. Sercu S, Zhang M, Oyama N, Hansen U, Ghalbzouri AEL, Jun G, Geentjens K, Zhang L, Merregaert JH. 2008. Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. J. Investig. Dermatol. 128:1397-1408. http://dx.doi.org/10.1038/sj.jid.5701231.
37. Khan S, Rodriguez E, Patel R, Gor J, Mulloy B, Perkins SJ. 2011. The solution structure of heparan sulfate differs from that of heparin: implications for function. J. Biol. Chem. 286:24842-24854. http://dx.doi.org /10.1074/jbc.M111.226027.
38. Rao CM, Salotra P, Datta K. 1999. Possible role of the 34-kilodalton hyaluronic acid-binding protein in visceral leishmaniasis. J. Parasitol. 85: 682-687. http://dx.doi.org/10.2307/3285743.
39. Han Z, Ni J, Smits P, Underhill CB, Xie B, Chen Y, Liu N, Tylzanowski P, Parmelee D, Feng P, Ding I, Gao F, Gentz R, Huylebroeck D, Merregaert J, Zhang L. 2001. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. FASEB J. 15:988-994. http://dx.doi.org/10.1096/fj.99-0934com.
40. Nanda A, St Croix B. 2004. Tumor endothelial markers: new targets for cancer therapy. Curr. Opin. Oncol. 16:44-49. http://dx.doi.org/10.1097 /00001622-200401000-00009.
41. Przybylski M. 2009. A review of the current research on the role of bFGF and VEGF in angiogenesis. J. Wound Care 18:516-519.
42. Kardami E, Pearson TW, Beecroft RP, Fandrich RR. 1992. Identification of basic fibroblast growth factor-like proteins in African trypanosomes and Leishmania. Mol. Biochem. Parasitol. 51:171-181. http://dx.doi.org /10.1016/0166-6851(92)90067-T.
43. Singh AK, Mukhopadhyay C, Biswas S, Singh VK, Mukhopadhyay CK. 2012. Intracellular pathogen Leishmania donovani activates hypoxia inducible factor-1 by dual mechanism for survival advantage within macrophage. PLoS One 7:e38489. http://dx.doi.org/10.1371/journal.pone.0038489.
44. Colhone MC, Arrais-Silva WW, Picoli C, Giorgio S. 2004. Effect of hypoxia on macrophage infection by Leishmania amazonensis. J. Parasitol. 90:510-515. http://dx.doi.org/10.1645/GE-3286.
45. Premanandan C, Lairmore MD, Fernandez S, Phipps AJ. 2006. Quantitative measurement of anthrax toxin receptor messenger RNA in primary mononuclear phagocytes. Microb. Pathog. 41:193-198. http://dx .doi.org/10.1016/j.micpath.2006.05.003.
46. Schnoor M, Cullen P, Lorkowski J, Stolle K, Robenek H, Troyer D, Rauterberg J, Lorkowski S. 2008. Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J. Immunol. 180:5707-5719. http://www.jimmunol.org/content /180/8/5707.long.
47. Nanda A, Carson-Walter EB, Seaman S, Barber TD, Stampfl J, Singh S, Vogelstein B, Kinzler KW, St Croix B. 2004. TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res. 64:817-820. http: //dx.doi.org/10.1158/0008-5472.CAN-03-2408.
48. Silva-Almeida M, Carvalho LO, Abreu-Silva AL, Souza CS, Hardoim DJ, Calabrese KS. 2012. Extracellular matrix alterations in experimental Leishmania amazonensis infection in susceptible and resistant mice. Vet. Res. 43:10. http://dx.doi.org/10.1186/1297-9716-43-10.
49. Antonicelli F, Bellon G, Debelle L, Hornebeck W. 2007. Elastin-elastases and inflamm-aging. Curr. Top. Dev. Biol. 79:99-155. http://dx.doi.org/10 .1016/S0070-2153(06)79005-6.
50. Heinz A, Jung MC, Duca L, Sippl W, Taddese S, Ihling C, Rusciani A, Jahreis G, Weiss AS, Neubert RHH, Schmelzer CEH. 2010. Degradation of tropoelastin by matrix metalloproteinases-cleavage site specificities and release of matrikines. FEBS J. 277:1939-1956. http://dx.doi.org/10 .1111/j.1742-4658.2010.07616.x.
51. Petersen CA, Greenlee MHW. 2011. Neurologic manifestations of Leishmania spp. infection. J. Neuroparasitology 2:N110401. http://www.ncbi .nlm.nih.gov/pmc/articles/PMC3110707/.
52. de Oliveira E, Oshiro ET, Pinto RV, de Castro BC, Daniel KB, de Oliveira JM, da Costa Lima MS, Jr, Guimarães EB, Silva JM, Dorval MEC. 2011. Presence of amastigotes in the central nervous system of hamsters infected with Leishmania sp. Rev. Bras. Parasitol. Vet. 20:97-102. http://dx.doi.org/10.1590/S1984-29612011000200002.
53. Wegrowski Y, Milard A-L, Kotlarz G, Toulmonde E, Maquart F-X, Bernard J. 2006. Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages. Clin. Exp. Immunol. 144:485-493. http://dx.doi.org/10.1111/j.1365-2249.2006.03059.x.